Halberd Corp. Issues Letter to Shareholders
JACKSON CENTER, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) today issued the following letter to...
JACKSON CENTER, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) today issued the following letter to...
STOCKHOLM, SE / ACCESSWIRE / August 26, 2024 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR)...
NEW YORK, Aug. 22, 2024 /PRNewswire/ -- The global cerebral and tissue oximetry devices market size is estimated to grow by...
NEW YORK, Aug. 22, 2024 /PRNewswire/ -- The global near-infrared (NIR) spectroscopy market size is estimated to grow by USD...
Company Announces $100 Million in Total Funding from New and Existing Investors to Advance Medical InnovationNEWARK, Calif.--(BUSINESS WIRE)--Openwater today announced...
Company Announces $100 Million in Total Funding from New and Existing Investors to Advance Medical InnovationNEWARK, Calif.--(BUSINESS WIRE)--Openwater today announced...
This year, AOA's Eye Deserve More campaign encourages consumers to prioritize their eye health as much as their technology ST....
Strategic Partnership with Existing Investor Sunstone Partners to Accelerate Knowtion's Leadership in Revenue Cycle Management NEW YORK, Aug. 22, 2024...
Novel FDA-cleared imaging technology reveals anatomy that traditional ultrasound devices cannot; initial focus on trauma as well as neurosurgery and...
neurocare is pleased to announce that it has received FDA clearance for its industry-leading intermittent Theta Burst Stimulation (iTBS) protocol,...
The agreement follows the successful completion of Phase 1 which evaluated the viability of LIBERTY as a remote telesurgery platform...
NEW YORK, Aug. 21, 2024 /PRNewswire/ -- The global 3D printing medical devices market size is estimated to grow by...
DehydraTECH-liraglutide is showing apparent superiority to DehydraTECH-semaglutideSelect DehydraTECH-CBD formulations are showing apparent superiority to DehydraTECH-GLP-1 at 4 and 8 weeks...
TORONTO, ON / ACCESSWIRE / August 21, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
NCD Will Integrate Firefly’s BNA Technology into its Patient Management Protocols for Enhanced Brain Function Insights and Improved Patient OutcomesTORONTO,...
• Falls and car accidents lead incidence of concussions in emergency departments • Spray-dried drug formulation allows for easy delivery to patients...
Burton J. Tabaac MD, FAHA and Rotem Petranker, M.A. Set to Bolster Rose Hill’s Psychedelic Research EffortsWORCESTER, Mass., Aug. 21,...
Leveraging proprietary EEG data from previous and future research studies with BRAIN AGE® Brain Health AI Accelerating clinical trial development...
Strategic equity investment of $15 M to support completion of Pharmazz's pivotal Phase 3 study for Sovateltide to treat patients...
Hevolution Foundation and Dolby Family Ventures join ND Capital as additional institutional investors bringing Series A funding to a total...